T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$3.17B |
| 2 |
Nike
NKE
|
+$1.94B |
| 3 |
Bank of America
BAC
|
+$1.84B |
| 4 |
FedEx
FDX
|
+$1.78B |
| 5 |
PNC Financial Services
PNC
|
+$1.61B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$4.1B |
| 2 |
Fortive
FTV
|
+$2.54B |
| 3 |
Linde
LIN
|
+$1.53B |
| 4 |
Alibaba
BABA
|
+$1.35B |
| 5 |
Willis Towers Watson
WTW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.61% |
| 2 | Healthcare | 16.74% |
| 3 | Consumer Discretionary | 15.8% |
| 4 | Financials | 11.46% |
| 5 | Communication Services | 10.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Iovance Biotherapeutics
IOVA
$2.95B
| $228M | 0.03% |
6,929,214
-343,216
| -5% | -$10.5M |
|
452
Western Alliance Bancorporation
WAL
$8.92B
| $227M | 0.03% |
7,168,712
+175,995
| +3% | +$6.26M |
|
|
ONC
453
BeOne Medicines Ltd
ONC
$40.3B
| $225M | 0.03% |
786,418
+189,163
| +32% | +$44.5M |
|
|
DNB
454
DELISTED
Dun & Bradstreet
DNB
| $225M | 0.03% |
+8,778,354
| New | +$223M |
|
455
Sprouts Farmers Market
SFM
$7.71B
| $225M | 0.03% |
10,733,542
+1,037,965
| +11% | +$24.9M |
|
456
AES
AES
$10.5B
| $223M | 0.03% |
12,340,191
+8,808,354
| +249% | +$147M |
|
457
ESCO Technologies
ESE
$7.79B
| $222M | 0.03% |
2,758,293
-2,888
| -0.1% | -$249K |
|
|
CVET
458
DELISTED
Covetrus, Inc. Common Stock
CVET
| $222M | 0.03% |
9,085,592
-555,866
| -6% | -$12M |
|
459
Southwest Gas
SWX
$6.67B
| $221M | 0.03% |
3,494,621
-390,548
| -10% | -$26.1M |
|
460
Xencor
XNCR
$1.71B
| $220M | 0.03% |
5,684,073
+284,578
| +5% | +$9.89M |
|
461
Outset Medical
OM
$79.9M
| $220M | 0.03% |
+305,292
| New | +$251M |
|
462
Landstar System
LSTR
$6.4B
| $220M | 0.03% |
1,750,443
-35,412
| -2% | -$4.46M |
|
463
Regency Centers
REG
$14.1B
| $218M | 0.03% |
5,728,023
+339,975
| +6% | +$14M |
|
|
MRTX
464
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $218M | 0.03% |
1,311,262
+2,410
| +0.2% | +$330K |
|
465
Bankunited
BKU
$3.41B
| $217M | 0.03% |
9,884,977
+706,866
| +8% | +$15M |
|
|
JBTM
466
JBT Marel
JBTM
$6.1B
| $216M | 0.03% |
2,352,254
-203,479
| -8% | -$19.5M |
|
467
Martin Marietta Materials
MLM
$32.7B
| $216M | 0.03% |
916,323
+3,547
| +0.4% | +$767K |
|
468
Alexandria Real Estate Equities
ARE
$8.33B
| $215M | 0.02% |
1,343,748
-10,572
| -0.8% | -$1.77M |
|
|
BSX.PRA
469
DELISTED
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
| $214M | 0.02% |
1,914,919
-100
| -0% | -$11.2K |
|
470
Five Below
FIVE
$13.4B
| $213M | 0.02% |
1,678,108
+8,610
| +0.5% | +$980K |
|
471
Snap-on
SNA
$20.9B
| $213M | 0.02% |
1,447,466
+46,687
| +3% | +$6.78M |
|
|
CUB
472
DELISTED
Cubic Corporation
CUB
| $210M | 0.02% |
3,610,958
-28,566
| -0.8% | -$1.34M |
|
473
Penumbra
PEN
$12.9B
| $210M | 0.02% |
1,080,008
-34,424
| -3% | -$7.24M |
|
474
Banco Santander Chile
BSAC
$16.1B
| $207M | 0.02% |
14,901,221
-1,323,643
| -8% | -$21.1M |
|
|
AEPPL
475
DELISTED
American Electric Power Company, Inc. Corporate Unit
AEPPL
| $206M | 0.02% |
4,249,522
+364,832
| +9% | +$18.1M |
|
Similar funds
T. Rowe Price Associates's Q3 2020 Portfolio in Review
As of Q3 2020, T. Rowe Price Associates held 2,679 positions worth $864B, up 8.7% from $795B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2020 filing shows 185 new, 873 increased, 1,330 reduced and 90 closed positions. Its largest new stake was nCino: 5,133,240 shares worth $395M. The largest sale was People Inc, an estimated $4.1B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2020 buy was nCino: 5,133,240 shares worth $395M.
- T. Rowe Price Associates added most to Match Group in Q3 2020, an estimated $3.17B increase.
- T. Rowe Price Associates's biggest Q3 2020 reduction was People Inc, cutting an estimated $4.1B.
- T. Rowe Price Associates fully exited 58.com Inc in Q3 2020, selling an estimated $468M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $864B portfolio in Q3 2020.
- T. Rowe Price Associates opened 185 new positions and closed 90 in Q3 2020.
- T. Rowe Price Associates's portfolio value rose 8.7% quarter-over-quarter to $864B.
Based on T. Rowe Price Associates's 13F filing for Q3 2020, filed 16 Nov 2020.